Total Payments
$19,402
2024 Payments
$2,958
Companies
35
Transactions
1,245
Medicare Patients
646
Medicare Billing
$104,389
Payment Breakdown by Category
Food & Beverage$19,322 (99.6%)
Education$80.34 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,322 | 1,243 | 99.6% |
| Education | $80.34 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $2,385 | 155 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,269 | 128 | $0 (2024) |
| Alkermes, Inc. | $1,677 | 103 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,624 | 112 | $0 (2022) |
| ABBVIE INC. | $1,537 | 110 | $0 (2024) |
| ITI, Inc. | $1,268 | 76 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,181 | 70 | $0 (2024) |
| Allergan, Inc. | $857.99 | 63 | $0 (2020) |
| Corium, LLC | $676.88 | 57 | $0 (2024) |
| Shire North American Group Inc | $657.94 | 36 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,958 | 177 | Alkermes, Inc. ($549.44) |
| 2023 | $2,959 | 204 | AbbVie Inc. ($613.12) |
| 2022 | $2,520 | 168 | ITI, Inc. ($529.11) |
| 2021 | $2,672 | 165 | Lundbeck LLC ($388.63) |
| 2020 | $1,032 | 63 | Otsuka America Pharmaceutical, Inc. ($199.40) |
| 2019 | $2,813 | 167 | Otsuka America Pharmaceutical, Inc. ($653.97) |
| 2018 | $2,162 | 141 | Lundbeck LLC ($417.79) |
| 2017 | $2,286 | 160 | Lundbeck LLC ($481.72) |
All Payment Transactions
1,245 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Central Nervous System | ||||||
| 12/18/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: CNS | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: CNS | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.11 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: CNS | ||||||
| 11/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CNS | ||||||
| 11/22/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.18 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: ADHD | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: CNS | ||||||
| 10/31/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Neuropsychiatry | ||||||
| 10/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 175 | 462 | $102,702 | $30,113 |
| 2022 | 3 | 178 | 500 | $107,390 | $26,639 |
| 2021 | 3 | 157 | 448 | $85,778 | $23,520 |
| 2020 | 2 | 136 | 466 | $85,520 | $24,118 |
Total Patients
646
Total Services
1,876
Medicare Billing
$104,389
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 188 | $52,264 | $16,772 | 32.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 71 | 217 | $39,504 | $10,373 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 57 | $10,934 | $2,967 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 160 | $44,480 | $11,708 | 26.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 70 | 237 | $43,134 | $10,321 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 103 | $19,776 | $4,610 | 23.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 213 | $40,896 | $11,610 | 28.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 68 | 213 | $38,766 | $10,125 | 26.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 22 | $6,116 | $1,785 | 29.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 67 | 232 | $41,379 | $12,176 | 29.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 234 | $44,141 | $11,942 | 27.1% |
About Dr. David Urrate, MD
Dr. David Urrate, MD is a Psychiatry healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598872871.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Urrate, MD has received a total of $19,402 in payments from pharmaceutical and medical device companies, with $2,958 received in 2024. These payments were reported across 1,245 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($19,322).
As a Medicare-enrolled provider, Urrate has provided services to 646 Medicare beneficiaries, totaling 1,876 services with total Medicare billing of $104,389. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Austin, TX
- Active Since 08/24/2006
- Last Updated 09/03/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1598872871
Products in Payments
- REXULTI (Drug) $3,270
- VRAYLAR (Drug) $2,395
- CAPLYTA (Drug) $1,783
- LATUDA (Drug) $1,624
- ARISTADA (Drug) $1,250
- TRINTELLIX (Drug) $1,040
- Trintellix (Drug) $751.36
- JORNAY PM (Drug) $571.61
- INGREZZA (Drug) $555.26
- VYVANSE (Drug) $538.91
- Azstarys (Drug) $535.62
- AUSTEDO (Drug) $502.10
- Adzenys XR-ODT (Drug) $453.89
- ABILIFY MAINTENA (Drug) $427.01
- LYBALVI (Drug) $426.74
- Auvelity (Drug) $410.48
- BRINTELLIX (Drug) $399.11
- SPRAVATO (Drug) $291.25
- MYDAYIS (Drug) $182.84
- Evekeo (Drug) $175.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Austin
Dr. Donald Garcia, Md, MD
Psychiatry — Payments: $4.0M
Psychiatry $4.0M
Dr. Arvinder Pal Walia, M.d, M.D
Psychiatry — Payments: $2.7M
Psychiatry $2.7M
Charles Nemeroff, Md Phd, MD PHD
Psychiatry — Payments: $400,808
Psychiatry $400,808
Dr. Divyansu Patel, M.d, M.D
Psychiatry — Payments: $319,461
Psychiatry $319,461
Frank Floca, Md, MD
Psychiatry — Payments: $99,177
Psychiatry $99,177
Dr. Charles Sweet, M.d., M.p.h, M.D., M.P.H
Psychiatry — Payments: $88,371
Psychiatry $88,371